Skip to main content
. 2021 May 27;14(8):101138. doi: 10.1016/j.tranon.2021.101138

Fig. 1.

Fig. 1

CD276 expression in esophagus carcinomas and healthy tissues. (A) IHC analysis of CD276 expression in malignant and healthy tissues from patients with ESCC (n = 91). (B) CD276 expression in EAC. IHC detection in malignant (n = 46) and marginal lesions (n = 21) from patients with EAC. (C) IHC of CD276 in 23 types of healthy tissues from four subjects. Scale bar, 50 μm. (D) ANOVA test of CD276 scores among healthy, marginal and malignant tissues. ***, P < 0.005; ###, P < 0.005.